Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC)

    • Cancer
    • Bladder Cancer
    • Muscle Invasive Urothelial Carcinoma